Suscribirse

IMAGING OF LUNG TRANSPLANTATION - 08/09/11

Doi : 10.1016/S0272-5231(05)70257-4 
Jo-Anne O. Shepard, MD *

Resumen

The first human lung transplantation was performed in 1963 but was unsuccessful. When cyclosporine was introduced in the early 1980s, the era of solid organ transplantation began. The first long-term success with human single lung transplantation, which was modeled on the concepts established for heart–lung transplantation at Stanford University, occurred in 1983 at the Toronto General Hospital. In 1986, the technique for double lung transplantation was successfully developed. The field of lung transplantation has evolved dramatically in the past 16 years. 2, 15, 21, 26, 32, 37, 50, 52, 53, 70, 72 One-year survival after lung transplantation is now 80% to 90% and 5-year survival is approximately 50%.21 The operative mortality rate is less than 10%. Lung transplantation is now an accepted treatment for a large number of end-stage pulmonary diseases, including, but not limited to, emphysema, cystic fibrosis, pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and primary pulmonary hypertension.

Several factors have led to the ultimate success of lung transplantation, including (1) improved recipient assessment and selection, (2) improved intensive care unit care, (3) better understanding of the mechanism of rejection and refinements in immunosuppressive regimens, (4) improved prevention, diagnosis, and treatment of infections, (5) improved surgical techniques to overcome problems of airway ischemia, and (6) development of effective rehabilitation programs.

Major challenges remain, however. 18, 19 The major obstacle to the growth of lung transplant programs is the limited supply of suitable donors. Only 20% to 30% of multi-organ donors have lungs that are suitable for transplantation because of the high incidence of complications such as aspiration pneumonia, atelectasis, and the pulmonary edema associated with donor brain death. More recently, the harvest of lower lobes from two living donors for double lung transplant has been performed successfully by several groups, thereby shortening the wait for a suitable donor.67 The development of obliterative bronchiolitis in up to 50% of long-term survivors remains another major challenge. Obliterative bronchiolitis is the major factor affecting long-term survival and quality of life. 32, 35

Several complications pertain specifically to lung transplant recipients, including airway ischemia, reperfusion edema, infections, acute rejection, obliterative bronchiolitis and other postoperative problems related to surgical technique and immunosuppressive therapy. Imaging procedures play an important role in the diagnosis and management of these problems. This article focuses on the imaging appearance of these complications.*

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Jo-Anne O. Shepard, MD, Department of Radiology–FND 202, Massachusetts General Hospital, Boston, MA 02114


© 1999  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.© 1998  © 1998  © 1998  © 1999  © 1998 
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 20 - N° 4

P. 827-844 - décembre 1999 Regresar al número
Artículo precedente Artículo precedente
  • INTERVENTIONAL TECHNIQUES IN THE THORAX
  • Jeffrey S. Klein
| Artículo siguiente Artículo siguiente
  • RADIOLOGIC EVALUATION OF EMPHYSEMA FOR LUNG VOLUME REDUCTION SURGERY
  • Ella A. Kazerooni

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.